We planned to investigate the association between Obstructive Sleep Apnea Syndrome (OSAS) and two common urological problems, namely Lower Urinary Tract Symptoms (LUTS) and Erectile Dysfunction (ED). An overnight polysomnograph test was performed for male patients over the age of 50 who presented to Düzce University Medical Faculty, Department of Chest Diseases with symptoms of OSAS. A total of 11 patients with moderate OSAS whose Apnea-Hypopnea index (AHI) was 15-30 and 18 patients with severe OSAS whose AHI was >30 were included in the study as the first group. The 21 OSAS negative patients with AHI <5 constituted the control group. Patients with diseases that could lead to LUTS and ED were excluded from the study for both groups. Urinary symptoms were evaluated with the International Prostate Symptom Score (IPSS), uroflowmetry, prostate volume. Erectile function was assessed according to the International Index of Erectile Function (IIEF). The groups were similar in terms of age, prostate specific antigen (PSA), prostate volume. No statistically significant difference was found between the groups in terms of IPSS values and uroflowmetry parameters (p>0.05). However, there was a statistically significant difference between the groups for nocturia episodes and IIEF scores (p<0.05). OSAS was not found to be an additional risk factor for LUTS other than nocturia. On the other hand, OSAS was related with ED and nocturia. We therefore believe patients with ED and/or nocturia should be evaluated for OSAS. It is also appropriate to investigate OSAS patients in terms of having ED.
1. Garraway WM, Collins CJ, Lee RJ. High prevalence of benign prostatic hypertrophy in the community. Lancet. 1991;338(2):469-71.
2. Chapple CR. Th etotal approach in the lower urinary tract symptoms. Benign prostatic hyperplasia (LUTS-BPH) management: Introduction and conclusion. Eur Urol. 2003;2(suppl):1-5.
3. Oelke M, Bachmann A, Descazeaud A, Emberton M, Gravas S, Michel MC, N'dow J, Nordling J, de la Rosette JJ. European Association of Urology. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction. Eur Urol. 2013;64(1):118- 40.
4. Saito M, Ohmura M, Kondo A. Effect of aging on blood flow to the bladder and bladder function. Urol Int. 1999;62(2):93-8.
5. AUA practice guidelines committee. AUA guideline on management of benign prostatic hyperplasia Chapter 1: Diagnosis and treatment recommendations. J Urol. 2003;170:530-47.
6. Hatzimouratidis K, Amar E, Eardley I, Hatzichristou D, Montorsi F, Vardi Y, Wespes E. European Association of Urology. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57(5):804-14.
7. Akkus E, Kadioglu A, Esen A, Doran S, Ergen A, Anafarta K, Hattat H. Prevalence and correlates of erectile dysfunction in Turkey: a population- based study. Eur Urol. 2002;41(3):298-304.
8. Myers KA, Mrkobrada M, Simel DL. Does this patient have obstructive sleep apnea?: The Rational Clinical Examination systematic review. JAMA. 2013;310(7):731-41.
9. Berry RB, Budhiraja R, Gottlieb DJ, Gozal D, Iber C, Kapur VK, Marcus CL, Mehra R, Parthasarathy S, Quan SF, Redline S, Strohl KP, Davidson Ward SL,Tangredi MM. American Academy of Sleep Medicine. Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med. 2012;8(5):597-619.
10. Dong JY, Zhang YH, Qin LQ. Obstructive sleep apnea and cardiovascular risk: meta-analysis of prospective cohort studies. Atherosclerosis. 2013;229(2):489-95.
11. Stiefel P, Sánchez-Armengol MA, Villar J, Vallejo-Vaz A, Moreno-Luna R, Capote F. Obstructive sleep apnea syndrome, vascular pathology, endothelial function and endothelial cells and circulating microparticles. Arch Med Res. 2013;44(6):409-14.
12. Barone DA, Krieger AC. Stroke and obstructive sleep apnea: a review. Curr Atheroscler Rep. 2013;15(7):334-8.
13. Blanker MH, Groeneveld FP, Prins A, Bernsen RM, Bohnen AM, Bosch JL. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status. BJU Int. 2000;85(6):665-71.
14. Tarcan T, Azadzoi KM, Siroky MB, Goldstein I, Krane RJ. Age-related erectile and voiding dysfunction: the role of arterial insufficiency. Br J Urol. 1998;82(suppl 1):26-33.
15. Win AJ. Assessing treatment results in benign prostatic hyperplasia. Urol Clin North Am. 1995;22(2):345-50.
16. Feldman H.A, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol. 1994;151(1):54-61.
17. Fairbanks D. Snoring: Surgical vs. nonsurgical management. Laryngoscope. 1984;94(9):1188-93.
18. Kemmer H, Mathes AM, Dilk O, Gröschel A, Grass C, Stöckle M. Obstructive sleep apnea syndrome is associated with overactive bladder and urgency incontinence in men. Sleep. 2009;32(2):271-5.
19. Arıcıgil M, Yiğit Ö, Alkan Çakır Z, Taşkın Ü, Toktaş G, Uzman Ö. Ağır OSAS'lı hastalarda CPAP kullanımının noktürnal pollaküriye etkisi. Turk Arch Otolaryngol. 2008;46:214-8.
20. Stewart RB, Moore MT, May FE, Marks RG, Hale WE. Nocturia: a risk factor for falls in the elderly. J Am Geri Soc 1992;40(12):1217-20.
21. Asplund R, Aberg H. Nocturnal micturition, sleep and well-being in women of ages 40-64 years. Maturitas. 1996;24(1-2):73-81.
22. Pressman MR, Figueroa WG, Kendrick-Mohamed J, Greenspon LW, Peterson DD. Nocturia. A rarely recognized symptom of sleep apnea and other occult sleep disorders. Arch Int Med. 1996;156:545-50.
23. Guilleminault C, Lin CM, Goncalves MA, Ramos E. A prospective study of nocturia and the quality of life of elderly patients with obstructive sleep apnea or sleep onset insomnia. J Psychosom Res. 2004;56(5):511-5.
24. Bing MH, Jennum P, Moller LA, Mortensen S, Lose G. Obstructive sleep apnea in a Danish population of men and women aged 60-80 years with nocturia. J Clin Sleep Med. 2012;15(8):515-20.
25. Perimenis P, Karkoulias K, Konstantinopoulos A, Perimeni PP, Katsenis G, Athanasopoulos A, Spyropoulos K. Sildenafil versus continous positive airway pressure for erectile dysfunctionin men with obstructive sleep apnea: a comparative study of their efficacy and safety and the patients satisfaction with treatment. Asian J Androl. 2007;9(2):259-64.
26. Perimenis P, Konstantinopoulos A, Karkoulias K, Markou S, Perimeni P, Spyropoulos K. Sildenafil combined with continous positive airway pressure for treatment of erectile dysfunction in men with obstructive sleep apnea. Int Urol Nephrol. 2007;39(2):547-52
27. Taskin U, Yigit O, Acioglu E, Aricigil M, Toktas G, Guzelhan Y. Erectile dysfunction in severe sleep apnea patients and response to CPAP. Int J Impot Res. 2010;22(2):134-9.
28. Margel D,Tal R, Livne PM, Pillar G. Predictors of erectile function improvement in obstructive sleep apnea patients with long term CPAP treatment. Int J Impot Res. 2005;17(2):186-90